Back to Search
Start Over
Effect on quality of life (QOL) of adding cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicentre, randomized, phase 3 MILES-3 and MILES-4 studies
- Source :
- Annals of Oncology. 28:v488
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
- Subjects :
- 0301 basic medicine
Oncology
Cisplatin
medicine.medical_specialty
business.industry
non-small cell lung cancer (NSCLC)
Hematology
Joint analysis
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Quality of life
030220 oncology & carcinogenesis
Internal medicine
medicine
Single agent
First line chemotherapy
business
medicine.drug
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 28
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........5c71bebf485a0e0761522459755c8b45